Strongyloides stercoralis: A cause of morbidity and mortality for indigenous people in Central Australia

Internal Medicine Journal

Volumn 38, Issue 9, 2008, Pages 697-703

  Einsiedel, L ^a   Fernandes, L ^b  

^a ALICE SPRINGS HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Human T cell lymphotropic virus type 1; Indigenous health; Strongyloidiasis

Indexed keywords

ALBENDAZOLE; AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; COLESTYRAMINE; FUROSEMIDE; GENTAMICIN; IVERMECTIN; PENICILLIN G; PERMETHRIN; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; AUSTRALIA; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIAL PERITONITIS; BACTERIAL PNEUMONIA; CAUSE OF DEATH; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DIARRHEA; DISEASE ASSOCIATION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; EPIGASTRIC PAIN; FECES ANALYSIS; FECES INCONTINENCE; FEMALE; HEPATITIS B; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HYPOTENSION; INDIGENOUS PEOPLE; INFECTION COMPLICATION; KLEBSIELLA PNEUMONIAE; LUNG EDEMA; MALE; MEDICAL AUDIT; MEDICAL RECORD REVIEW; MIXED INFECTION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; SCABIES; SEPTICEMIA; SERODIAGNOSIS; SINGLE DRUG DOSE; STREPTOCOCCUS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; THORAX PAIN; VOMITING; WHEEZING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; MORBIDITY; NORTHERN TERRITORY; POPULATION GROUPS; RETROSPECTIVE STUDIES; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 54949112818     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01775.x     Document Type: Article

References (29)

1. Grove D. Human strongyloidiasis. Adv Parasitol 1996 38 : 251 309.
2. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 1981 3 : 397 407.
3. Prociv P, Luke R. Observations on strongyloidiasis in Queensland Aboriginal communities. Med J Aust 1993 158 : 160 63.
4. Grove DI. Strongyloidiasis in allied ex-prisoners of war in south-east Asia. BMJ 1980 180 : 598 601.
5. Einsiedel L, Spelman D. Strongyloides stercoralis: risks posed to immigrant patients in an Australian tertiary referral centre. Intern Med J 2006 36 : 632 7.
6. Page W, Dempsey K, McCarthy JS. Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy. Trans R Soc Trop Med Hyg 2006 100 : 1056 62.
7. Fisher D, McCarry F, Currie B. Strongyloidiasis in the Northern Territory: under-recognised and under-treated. Med J Aust 1993 159 : 88 90.
8. Davis JS, Currie BJ, Fisher DA, Huffam SE, Anstey NM, Price PN et al. Prevention of opportunistic infections in immunocompromised patients in the tropical top end of the Northern Territory. Commun Dis Intell 2003 27 : 526 32.
9. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insight into the prevention of disseminated disease. Rev Infect Dis 1989 11 : 755 67.
10. Bastian I, Hinuma Y, Doherty R. HTLV-1 among Northern Territory Aborigines. Med J Aust 1993 159 : 12 16.
11. Verdonck K, Gonzalez E, Van Dooren S, Vandamme A, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007 7 : 266 81.
12. Mollison L, Lo ST, Marning G. HTLV-1 and scabies in Australian Aborigines. Lancet 1993 341 : 1281 2.
13. Rajabalendaran N, Burns R, Mollison L. Tropical spastic paraparesis in an Aborigine. Med J Aust 1993 159 : 28 9.
14. Nakada K, Kohakura M, Komoda H, Hinuma K. High incidence of HTLV-1 antibody in carriers of Strongyloides stercoralis. Lancet. 1984 1 : 633.
15. Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A et al. Impairment of host immune response against Strongyloides stercoralis by human T cell lymphotropic virus type I. Am J Trop Med Hyg 2006 74 : 246 9.
16. Gotuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM et al. Strongyloides stercoralis hyperinfection associated with Human T cell Lymphotropic virus type 1 infection in Peru. Am J Trop Med Hyg 1999 60 : 146 9.
17. Carvalho EM, Porto AF. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 2004 26 : 487 97.
18. Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev 2004 17 : 208 17.
19. Porto AF, Filo JO, Neva FA, Orge G, Alcantara L, Gam A, Carvalho EM. Influence of human T-cell lymphotropic virus type I infection on serological and skin tests for strongyloidiasis. Am J Trop Med Hyg 2001 65 : 610 13.
20. Bastian I. HTLV-1 Studies in the Northern Territory. Darwin : Menzies School of Health Research, University of Sydney 1996.
21. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001 33 : 1040 47.
22. Marti H, Haji HJ, Savioli L, Chwaya HM, Mgeni AF, Ameir JS et al. A comparative trial of a single dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 1996 55 : 477 81.
23. Nontasut P, Muennoo C, Sa-nguankiat S, Fongsri S, Vichit A. Prevalence of strongyloides in northern Thailand and treatment with ivermectin vs albendazole. Southeast Asian J Trop Med Public Health 2005 36 : 442 4.
24. Satoh M, Toma H, Sato Y, Takara M, Shiroma Y, Kiyuna S et al. Reduced efficacy of treatment of strongyloidiasis in HTLV-1 carriers related to enhanced expression of IFN gamma and TGF beta. Clin Exp Immunol 2002 127 : 354 9.
25. Zaha O, Hirata T, Uchima N, Kinjo F, Saito A. Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody. J Infect Chemother 2004 10 : 348 51.
26. Kobayashi J, Sato Y, Toma H, Takara M, Shiroma Y. Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis. Diagn Microbiol Infect Dis 1994 18 : 19 23.
27. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002 66 : 749 52.
28. McDonald MI, Towers RJ, Andrews, RM, Benger N, Currie BJ, Carapetis JR. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian Aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 2006 43 : 683 9.
29. Bailie RSS, Stevens MR, McDonald E, Halpin S, Brewster D, Robinson G et al. Skin infection, housing and social circumstances in children living in remote indigenous communities: testing conceptual and methodological approaches. BMC Public Health 2005 5 : 128 39.